Ionis Pharmaceuticals Inc (IONS)
33.94
-1.46
(-4.12%)
USD |
NASDAQ |
Nov 21, 16:00
33.94
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Liabilities (Quarterly): 2.419B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.419B |
| June 30, 2024 | 2.427B |
| March 31, 2024 | 2.467B |
| December 31, 2023 | 2.603B |
| September 30, 2023 | 2.619B |
| June 30, 2023 | 2.543B |
| March 31, 2023 | 2.399B |
| December 31, 2022 | 1.961B |
| September 30, 2022 | 1.828B |
| June 30, 2022 | 1.831B |
| March 31, 2022 | 1.810B |
| December 31, 2021 | 1.840B |
| September 30, 2021 | 1.884B |
| June 30, 2021 | 1.914B |
| March 31, 2021 | 1.568B |
| December 31, 2020 | 1.646B |
| September 30, 2020 | 1.489B |
| June 30, 2020 | 1.484B |
| March 31, 2020 | 1.521B |
| December 31, 2019 | 1.549B |
| September 30, 2019 | 1.397B |
| June 30, 2019 | 1.421B |
| March 31, 2019 | 1.448B |
| December 31, 2018 | 1.481B |
| September 30, 2018 | 1.408B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.430B |
| March 31, 2018 | 912.46M |
| December 31, 2017 | 957.49M |
| September 30, 2017 | 854.89M |
| June 30, 2017 | 875.26M |
| March 31, 2017 | 882.19M |
| December 31, 2016 | 812.90M |
| September 30, 2016 | 703.95M |
| June 30, 2016 | 699.90M |
| March 31, 2016 | 717.66M |
| December 31, 2015 | 747.11M |
| September 30, 2015 | 742.59M |
| June 30, 2015 | 675.94M |
| March 31, 2015 | 679.58M |
| December 31, 2014 | 698.03M |
| September 30, 2014 | 449.03M |
| June 30, 2014 | 450.92M |
| March 31, 2014 | 460.51M |
| December 31, 2013 | 468.77M |
| September 30, 2013 | 480.47M |
| June 30, 2013 | 387.57M |
| March 31, 2013 | 351.87M |
| December 31, 2012 | 362.92M |
| September 30, 2012 | 315.40M |
| June 30, 2012 | 318.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.484B
Minimum
Jun 2020
2.619B
Maximum
Sep 2023
1.990B
Average
1.862B
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen Inc | 11.95B |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Amicus Therapeutics Inc | 607.73M |
| Arbutus Biopharma Corp | 33.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.081B |
| Shareholders Equity (Quarterly) | 662.47M |
| Debt to Equity Ratio | 1.930 |
| Current Ratio | 8.910 |
| Net Debt Paydown Yield | 0.12% |